Acura Pharmaceuticals Inc (NASDAQ:ACUR)

Data as of Sep 17
 -0.01 / -1.20%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company, which is engaged in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Contact Information

Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine Illinois 60067-8121
P:(847) 705-7709
Investor Relations:



Mutual fund holders2.36%
Individual stakeholders119.97%
Other institutional1.28%

Top Executives

Robert B. JonesPresident, Chief Executive Officer & Director
Peter A. ClemensChief Financial Officer, Secretary & Senior VP
Albert W. BrzeczkoVice President-Technical Affairs
Robert A. SeiserTreasurer, Vice President & Controller
James F. EmighVice President-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.